{"transactions":[{"id":972756,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-11T16:18:02.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":480000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest on the first anniversary measured from November 17, 2025 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company."}],"balance_after":480000,"derivative":{"exercise_price":10.51,"expiration_date":"2035-12-08","underlying":"Common Stock","underlying_shares":480000},"source":{"system":"sec-edgar","filing":"0001193125-25-315989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872280/000119312525315989/ownership.xml","form_type":"4"}},{"id":1136243,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T20:30:14.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or May 21, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":19000,"derivative":{"exercise_price":0.3202,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-25-014482","document":"form4-05232025_040506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588925014482/form4-05232025_040506.xml","form_type":"4"}},{"id":1295692,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-24T16:15:38.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":4.37,"value":524400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":120000,"derivative":{"exercise_price":4.37,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001562180-25-000505","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872280/000156218025000505/primarydocument.xml","form_type":"4"}},{"id":1481431,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T21:06:05.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 11, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder\nmeeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":19000,"derivative":{"exercise_price":0.709,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-24-016693","document":"form4-06132024_090600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924016693/form4-06132024_090600.xml","form_type":"4"}},{"id":1540136,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-04-17T16:01:57.000Z","date":"2024-04-16","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":6.03,"value":1658250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on April 16, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested."}],"balance_after":275000,"derivative":{"exercise_price":6.03,"expiration_date":"2034-04-15","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001562180-24-003439","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872280/000156218024003439/primarydocument.xml","form_type":"4"}},{"id":1831214,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T20:50:24.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":14550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or July 10, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":14550,"derivative":{"exercise_price":1.22,"expiration_date":"2033-07-09","underlying":"Common Stock","underlying_shares":14550},"source":{"system":"sec-edgar","filing":"0001209191-23-042098","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123042098/doc4.xml","form_type":"4"}},{"id":1831213,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-12T20:50:24.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":4466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or July 10, 2024, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":8932,"source":{"system":"sec-edgar","filing":"0001209191-23-042098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123042098/doc4.xml","form_type":"4"}},{"id":2022957,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-10T16:49:26.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments through February 8, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":108000,"derivative":{"exercise_price":34.2,"expiration_date":"2033-02-08","underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0000899243-23-004592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872280/000089924323004592/doc4.xml","form_type":"4"}},{"id":2233357,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-14T20:15:23.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":14550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":14550,"derivative":{"exercise_price":2.05,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":14550},"source":{"system":"sec-edgar","filing":"0001209191-22-036667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919122036667/doc4.xml","form_type":"4"}},{"id":2233356,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T20:15:23.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":4466,"source":{"system":"sec-edgar","filing":"0001209191-22-036667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919122036667/doc4.xml","form_type":"4"}},{"id":2414407,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T18:15:31.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":90000,"derivative":{"exercise_price":18.51,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0000899243-22-004673","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872280/000089924322004673/doc4.xml","form_type":"4"}},{"id":2454576,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-03T16:16:04.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":121371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on July 26, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":121371,"derivative":{"exercise_price":19.77,"expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":121371},"source":{"system":"sec-edgar","filing":"0000899243-22-000130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872280/000089924322000130/doc4.xml","form_type":"4"}},{"id":2620679,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-02T20:20:34.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the shares underlying the option granted shall vest and become exercisable each month following July 30, 2021, over three years such that the options shall be 100% vested on July 30, 2024, subject to the grantee's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through each such vesting date."}],"balance_after":16667,"derivative":{"exercise_price":7.89,"expiration_date":"2031-07-29","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000899243-21-030982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000089924321030982/doc4.xml","form_type":"4"}},{"id":2624042,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":71808,"kind":"person","name":"Humer Kristian","position":1,"cik":"0001872280","reported_name":"Humer Kristian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-27T17:02:06.000Z","date":"2021-07-26","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on July 26, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":360000,"derivative":{"exercise_price":17.09,"expiration_date":"2031-07-26","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0000899243-21-030131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872280/000089924321030131/doc4.xml","form_type":"4"}}]}